Glucagon-like peptide 1 receptor agonists and thyroid cancer: is it the time to be concerned?

被引：15
作者：
Lisco, Giuseppe [1 ]
De Tullio, Anna [1 ]
Disoteo, Olga [2 ]
Piazzolla, Giuseppina [1 ]
Guastamacchia, Edoardo [1 ]
Sabba, Carlo [1 ]
De Geronimo, Vincenzo [3 ]
Papini, Enrico [4 ]
Triggiani, Vincenzo [1 ]
机构：
[1] Univ Bari Aldo Moro, Sch Med, Interdisciplinary Dept Med, Sect Internal Med Geriatr Endocrinol & Rare Dis, Piazza Giulio Cesare, Bari, Italy
[2] ASST Grande Osped Metropolitano Niguarda, Diabetol Unit, Milan, Italy
[3] Policlin Morgagni CCD, Unit Endocrinol, Catania, Italy
[4] Regina Apostolorum Hosp, Dept Endocrinol & Metab, Rome, Italy
来源：
ENDOCRINE CONNECTIONS | 2023年 / 12卷 / 11期
基金：
英国科研创新办公室;
关键词：
dipeptidyl peptidase IV; glucagon-like peptide 1 receptor agonist; incretin system; medullary thyroid cancer; papillary thyroid cancer; GLP-1; RECEPTOR; CALCITONIN CONCENTRATIONS; LIRAGLUTIDE; RISK; IV; METASTASIS; EXPRESSION; BENEFITS; INCREASE; OBESITY;
D O I：
10.1530/EC-23-0257
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have changed considerably the management of type 2 diabetes (T2D). However, recently published data from retrospective cohort studies suggest that chronic exposure to GLP-1RAs in T2D may increase the risk of papillary and medullary thyroid cancer. In this perspective, the role of the incretin system in thyroid carcinogenesis has been reviewed and critically commented on, aiming to understand if the time has arrived to be concerned about the risk. Although evidence suggested, speculative hypotheses should be verified, and further studies are urgently needed to clarify the issue.
引用
收藏
页数：7
相关论文
共 61 条
[21]   The DPP-IV inhibitor saxagliptin promotes the migration and invasion of papillary thyroid carcinoma cells via the NRF2/HO1 pathway [J].
He, Liang ;
Zhang, Ting ;
Sun, Wei ;
Qin, Yuan ;
Wang, Zhihong ;
Dong, Wenwu ;
Zhang, Hao .
MEDICAL ONCOLOGY, 2020, 37 (11)
[22]   Dipeptidyl Peptidase-4 Stabilizes Integrin α4β1 Complex to Promote Thyroid Cancer Cell Metastasis by Activating Transforming Growth Factor-Beta Signaling Pathway [J].
He, Qingyuan ;
Cao, Hongxin ;
Zhao, Yuelei ;
Chen, Pu ;
Wang, Na ;
Li, Wenyuan ;
Cui, Rongrong ;
Hou, Peng ;
Zhang, Xiaozhi ;
Ji, Meiju .
THYROID, 2022, 32 (11) :1411-1422
[23]   No Evidence of Increase in Calcitonin Concentrations or Development of C-Cell Malignancy in Response to Liraglutide for Up to 5 Years in the LEADER Trial [J].
Hegedus, Laszlo ;
Sherman, Steven I. ;
Tuttle, R. Michael ;
von Scholten, Bernt J. ;
Rasmussen, Soren ;
Karsbol, Julie D. ;
Daniels, Gilbert H. .
DIABETES CARE, 2018, 41 (03) :620-622
[24]   Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial [J].
Hernandez, Adrian F. ;
Green, Jennifer B. ;
Janmohamed, Salim ;
D'Agostino, Ralph B., Sr. ;
Granger, Christopher B. ;
Jones, Nigel P. ;
Leiter, Lawrence A. ;
Rosenberg, Anne E. ;
Sigmon, Kristina N. ;
Somerville, Matthew C. ;
Thorpe, Karl M. ;
McMurray, John J. V. ;
Del Prato, Stefano .
LANCET, 2018, 392 (10157) :1519-1529
[25]   Dipeptidyl peptidase IV (DPP IV/CD26) staining predicts distant metastasis of 'benign' thyroid tumor [J].
Hirai, K ;
Kotani, T ;
Aratake, Y ;
Ohtaki, S ;
Kuma, K .
PATHOLOGY INTERNATIONAL, 1999, 49 (03) :264-265
[26]   Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials [J].
Hu, Weiting ;
Song, Rui ;
Cheng, Rui ;
Liu, Caihong ;
Guo, Rui ;
Tang, Wei ;
Zhang, Jie ;
Zhao, Qian ;
Li, Xing ;
Liu, Jing .
FRONTIERS IN ENDOCRINOLOGY, 2022, 13
[27]   DPP4 gene silencing inhibits proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through suppression of the MAPK pathway [J].
Hu, X. ;
Chen, S. ;
Xie, C. ;
Li, Z. ;
Wu, Z. ;
You, Z. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (08) :1609-1623
[28]   Overdiagnosis and overtreatment of thyroid cancer: A population-based temporal trend study [J].
Jegerlehner, Sabrina ;
Bulliard, Jean-Luc ;
Aujesky, Drahomir ;
Rodondi, Nicolas ;
Germann, Simon ;
Konzelmann, Isabelle ;
Chiolero, Arnaud .
PLOS ONE, 2017, 12 (06)
[29]   Should we be concerned about thyroid cancer in patients taking glucagon-like peptide 1 receptor agonists? [J].
Kannan, Subramanian ;
Nasr, Christian .
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2014, 82 (03) :142-144
[30]   Dipeptidyl peptidase IV expression in thyroid cytology:: retrospective histologically confirmed study [J].
Kholová, I ;
Ryska, A ;
Ludvíková, M ;
Cáp, J ;
Pecen, L .
CYTOPATHOLOGY, 2003, 14 (01) :27-31
1234567